Physician profile
Stephen Larson
NPI 1972980928
$2,284.51
in general payments reported to CMS, 2019-2025
16 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $96.51 · 2021: $201 · 2022: $949 · 2023: $472 · 2024: $190 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977 · Education: $61.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.14 |
| Education | $61.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $863.12 | 2022-2023 | Scopis Ent |
| Inspire Medical Systems, INC. | $348.89 | 2023-2024 | Inspire |
| Ambu INC. | $218.47 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $205.49 | 2021-2025 | Dupixent |
| Optinose US, INC. | $154.29 | 2021-2025 | |
| Glaxosmithkline, LLC. | $102.00 | 2024-2025 | Nucala |
| Steris Corporation | $96.51 | 2020 | |
| Integra Lifesciences Corporation | $75.92 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Genzyme Corporation | $51.66 | 2024-2025 | |
| Smith+Nephew, INC. | $46.90 | 2025 | |
| Acclarent, INC | $27.20 | 2023 | Acclarent Aera, Trudi Nav Cable |
| Medtronic, INC. | $23.75 | 2025 | Propel |
| Astrazeneca Pharmaceuticals Lp | $20.40 | 2025 | Tezspire |
| Allergan, INC. | $20.15 | 2021 | |
| Kaleo, INC. | $18.58 | 2024 | Auvi-Q |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.